— Know what they know.
Not Investment Advice

DOCS NYSE

Doximity, Inc.
1W: +6.0% 1M: +6.1% 3M: +22.2% YTD: -35.5% 1Y: -60.5% 3Y: +35.3% 5Y: -67.6%
$27.93
-0.57 (-2.00%)
 
Weekly Expected Move ±6.7%
$24 $26 $28 $30 $32
NYSE · Healthcare · Medical - Healthcare Information Services · Tech Score Buy · Power 67 · $5.2B mcap · 181M float · 2.33% daily turnover · Short 48% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
64.8 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 79.3%  ·  5Y Avg: 78.9%
Cost Advantage
60
Intangibles
67
Switching Cost
63
Network Effect
52
Scale ★
83
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. DOCS has a Narrow competitive edge (64.8/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Efficient Scale. ROIC of 79.3% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$24
Low
$33
Avg Target
$41
High
Based on 7 analysts since Aug 6, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 8Hold: 13Sell: 2Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$33.29
Analysts7
Consensus Change History
DateFieldFromTo
2026-05-15 consensus Buy Hold
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-09-29 Evercore ISI Elizabeth Anderson $40 $35 -5 +33.6% $26.20
2026-09-08 Stifel Nicolaus — Initiated $27 — +2.5% $26.35
2026-08-13 Truist Financial Jailendra Singh $19 $24 +5 -4.0% $24.99
2026-08-07 Needham Scott Berg $27 $41 +14 +35.8% $30.19
2026-08-07 Evercore ISI Elizabeth Anderson $81 $40 -41 +93.6% $20.66
2026-08-07 BMO Capital — $20 $30 +10 +45.2% $20.66
2026-08-07 Canaccord Genuity — $30 $36 +6 +74.2% $20.66
2026-05-14 Barclays — $63 $20 -43 +11.0% $18.01
2026-05-14 Truist Financial Jailendra Singh $29 $19 -10 +6.3% $17.87
2026-05-14 BMO Capital Sean Dodge $25 $20 -5 -14.5% $23.39
2026-05-14 Needham Scott Berg $55 $27 -28 +15.4% $23.39
2026-05-14 Mizuho Securities — $45 $26 -19 +11.2% $23.39
2026-05-14 Canaccord Genuity — $34 $30 -4 +28.3% $23.39
2026-05-14 Goldman Sachs — $34 $24 -10 +2.6% $23.39
2026-05-14 Morgan Stanley Craig Hettenbach $49 $35 -14 +49.6% $23.39
2026-05-14 Leerink Partners Michael Cherny Initiated $25 — +6.9% $23.39
2026-05-14 Wells Fargo — $32 $18 -14 -23.0% $23.39
2026-05-14 Jefferies — Initiated $19 — -18.8% $23.39
2026-05-14 Robert W. Baird Vikram Kesavabhotla Initiated $18 — -23.0% $23.39
2026-05-11 Wells Fargo — $45 $32 -13 +23.2% $25.98
2026-04-19 Truist Financial — $37 $29 -8 +17.4% $24.71
2026-03-17 Loop Capital Markets Gene Mannheimer Initiated $31 — +24.4% $24.91
2026-02-20 Piper Sandler — $40 $42 +2 +66.5% $25.23
2026-02-09 Canaccord Genuity Richard Close $48 $34 -14 +22.6% $27.73
2026-02-06 KeyBanc — $60 $38 -22 +40.3% $27.09
2026-02-06 Truist Financial Jailendra Singh $62 $37 -25 +45.2% $25.49
2026-02-06 Goldman Sachs — $49 $34 -15 +36.4% $24.93
2026-02-06 Morgan Stanley — $65 $49 -16 +99.1% $24.61
2026-02-06 BMO Capital — Initiated $25 — +0.6% $24.86
2026-02-06 BTIG David Larsen Initiated $50 — +50.1% $33.32
2026-02-06 Needham Scott Berg $65 $55 -10 +65.1% $33.32
2026-02-06 Piper Sandler Jessica Tassan $39 $40 +1 +20.0% $33.32
2026-02-06 Wells Fargo — $55 $45 -10 +35.1% $33.32
2026-02-04 Mizuho Securities — Initiated $45 — +29.1% $34.85
2026-01-20 Wells Fargo Stan Berenshteyn $43 $55 +12 +33.3% $41.26
2026-01-09 Goldman Sachs David Roman $64 $49 -15 +12.0% $43.74
2026-01-08 RBC Capital — Initiated $59 — +34.9% $43.74
2026-01-08 Truist Financial Jailendra Singh $52 $62 +10 +37.7% $45.02
2026-01-08 KeyBanc — $80 $60 -20 +29.1% $46.49
2026-01-08 Canaccord Genuity Richard Close $50 $48 -2 +3.2% $46.49
2026-01-08 Canaccord Genuity — $67 $50 -17 +9.6% $45.62
2025-12-15 Morgan Stanley — $25 $65 +40 +48.3% $43.82
2025-12-08 Barclays Glen Santangelo $52 $63 +11 +37.9% $45.68
2025-10-08 Evercore ISI — $45 $81 +36 +13.5% $71.38
2025-10-08 KeyBanc Scott Schoenhaus $65 $80 +15 +12.1% $71.38
2025-10-01 Goldman Sachs David Roman $50 $64 +14 -12.5% $73.15
2025-09-18 Canaccord Genuity Richard Close $60 $67 +7 -9.0% $73.60
2025-09-10 Raymond James — $65 $75 +10 +8.7% $69.00
2025-05-20 Goldman Sachs David Roman Initiated $50 — -5.7% $53.00
2025-05-16 Truist Financial Jailendra Singh $49 $52 +3 -1.1% $52.56

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A-
Oct 02, 2026
DCF
5
ROE
4
ROA
5
D/E
2
P/E
2
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. DOCS receives an overall rating of A-. Strongest factors: DCF (5/5), ROE (4/5), ROA (5/5). Areas of concern: D/E (2/5), P/E (2/5), P/B (2/5).
Rating Change History
DateFromTo
2026-10-01 A A-
2026-05-13 A- A
2026-04-24 B+ A-
2026-04-01 A- B+
2026-02-24 A A-
2026-02-06 A- A

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 72 Grade A+
Profitability
73
Balance Sheet
94
Earnings Quality
56
Growth
42
Value
50
Momentum
71
Safety
100
Cash Flow
95
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. DOCS scores highest in Safety (100/100) and lowest in Growth (42/100). An overall grade of A+ places DOCS among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
17.86
Safe Zone
Piotroski F-Score
6/9
✓ ✓ ✗ ✓ ✓ ✗ ✓ ✗ ✓
Beneish M-Score
-2.91
Unlikely Manipulator
Ohlson O-Score
-13.70
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA+
Score: 93.1/100
Trend: Stable
Earnings Quality
75/100
OCF/NI: 1.67x
Accruals: -10.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. DOCS scores 17.86, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. DOCS scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. DOCS's score of -2.91 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. DOCS's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. DOCS receives an estimated rating of AA+ (score: 93.1/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). DOCS's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
31.38x
PEG
-1.09x
P/S
7.97x
P/B
5.57x
P/FCF
14.31x
P/OCF
13.92x
EV/EBITDA
14.30x
EV/Revenue
5.90x
EV/EBIT
15.22x
EV/FCF
11.99x
Earnings Yield
4.31%
FCF Yield
6.99%
Shareholder Yield
9.50%
Graham Number
$10.50
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 31.4x earnings, DOCS commands a growth premium. Graham's intrinsic value formula yields $10.50 per share, 166% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.784
NI / EBT
×
Interest Burden
1.000
EBT / EBIT
×
EBIT Margin
0.388
EBIT / Rev
×
Asset Turnover
0.540
Rev / Assets
×
Equity Multiplier
1.174
Assets / Equity
=
ROE
19.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. DOCS's ROE of 19.3% is driven by Asset Turnover (0.540), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$38.70
Price/Value
0.60x
Margin of Safety
39.80%
Premium
-39.80%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with DOCS's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. DOCS actually compounded EPS at 23.8% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. DOCS trades at a -40% premium to its adjusted intrinsic value of $38.70, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 31.4x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1325 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$27.93
Median 1Y
$19.80
5th Pctile
$6.64
95th Pctile
$59.22
Ann. Volatility
67.1%
Analyst Target
$33.29
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Jeff Tangney,
Chief Executive Officer
$627,000 $18,955,899 $19,586,169
John T. Vaughan,
General Counsel
$225,379 $3,214,231 $3,445,790
Anna Bryson, Financial
ief Financial Officer
$369,792 $2,000,000 $2,549,081
Jennifer Chaloemtiarana, Counsel
General Counsel
$218,783 $1,233,421 $1,778,065
Sid Sitaram, Accounting
unting Officer
$328,334 $512,031 $917,680

CEO Pay Ratio

75:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $19,586,169
Avg Employee Cost (SGA/emp): $260,131
Employees: 880

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
880
+6.0% YoY
Revenue / Employee
$732,799
Rev: $644,863,000
Profit / Employee
$222,785
NI: $196,051,000
SGA / Employee
$260,131
Avg labor cost proxy
R&D / Employee
$148,525
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
ROE 3.6% 8.1% 14.1% 17.6% 18.5% 17.1% 13.4% 12.2% 12.6% 14.1% 15.3% 15.8% 16.9% 19.0% 21.2% 22.5% 24.3% 24.6% 23.8% 19.3% 19.28%
ROA 3.2% 7.2% 12.7% 15.6% 16.0% 14.9% 11.9% 10.6% 10.8% 12.0% 13.3% 13.3% 14.4% 16.2% 18.5% 19.0% 20.6% 21.3% 20.6% 16.4% 16.42%
ROIC 9.4% 2.0% 1.6% 1.9% 1.1% 96.1% 79.3% 75.3% 81.8% 69.8% 72.3% 85.3% 80.2% 90.8% 88.3% 1.1% 1.0% 95.8% 81.2% 79.3% 79.34%
ROCE 3.4% 6.4% 10.2% 12.9% 11.9% 12.9% 12.5% 12.5% 13.0% 15.8% 18.2% 18.4% 20.1% 20.5% 21.1% 21.6% 24.7% 24.7% 27.4% 25.8% 25.81%
Gross Margin 89.0% 88.7% 88.7% 87.4% 85.6% 87.1% 88.3% 87.7% 87.9% 88.8% 91.0% 89.4% 89.3% 90.0% 91.6% 89.5% 89.2% 90.3% 89.9% 86.7% 86.65%
Operating Margin 34.2% 31.4% 36.6% 29.8% 23.9% 31.4% 33.4% 29.6% 27.4% 29.7% 43.3% 35.5% 36.4% 38.8% 47.4% 35.2% 37.4% 37.8% 38.9% 17.1% 17.08%
Net Margin 36.2% 45.5% 56.9% 39.2% 24.7% 25.7% 29.0% 27.6% 26.2% 26.9% 35.4% 34.4% 32.7% 32.3% 44.6% 45.2% 36.5% 36.8% 33.3% 13.1% 13.15%
EBITDA Margin 35.8% 32.9% 38.0% 31.3% 26.5% 33.9% 35.7% 32.0% 29.8% 39.0% 45.1% 37.6% 38.4% 42.4% 49.0% 44.3% 45.9% 46.3% 45.8% 24.9% 24.94%
FCF Margin 44.5% 33.2% 30.4% 35.2% 36.3% 39.2% 43.0% 41.4% 42.7% 35.8% 34.5% 37.5% 32.9% 42.1% 42.2% 46.8% 48.7% 50.2% 48.2% 49.2% 49.23%
OCF Margin 45.7% 34.4% 31.9% 36.8% 38.2% 41.2% 44.8% 42.9% 44.0% 36.9% 35.6% 38.7% 34.1% 43.3% 43.4% 47.9% 49.9% 51.5% 49.5% 50.6% 50.62%
ROE 3Y Avg snapshot only 19.20%
ROE 5Y Avg snapshot only 17.38%
ROA 3Y Avg snapshot only 16.26%
ROIC 3Y Avg snapshot only 66.96%
ROIC Economic snapshot only 17.78%
Cash ROA snapshot only 29.05%
Cash ROIC snapshot only 1.54%
CROIC snapshot only 1.49%
NOPAT Margin snapshot only 26.14%
Pretax Margin snapshot only 38.77%
R&D / Revenue snapshot only 20.27%
SGA / Revenue snapshot only 35.50%
SBC / Revenue snapshot only 18.86%
Valuation
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
P/E Ratio 436.55 280.17 91.89 72.65 49.62 45.84 59.87 61.06 60.79 36.02 40.84 36.67 34.71 50.15 53.63 52.78 52.48 58.03 36.85 23.18 31.382
P/S Ratio 158.13 115.02 43.41 32.73 20.70 16.82 17.72 16.44 16.54 9.89 12.00 11.38 11.29 16.89 19.63 20.65 20.93 23.63 13.83 7.05 7.968
P/B Ratio 15.77 22.63 12.93 12.80 8.30 7.36 7.65 7.13 7.29 5.09 6.50 6.00 6.10 9.08 10.47 10.88 12.03 13.40 9.01 4.78 5.566
P/FCF 355.07 346.83 142.69 93.02 57.07 42.88 41.22 39.72 38.75 27.66 34.78 30.35 34.35 40.17 46.53 44.16 42.94 47.05 28.72 14.31 14.312
P/OCF 346.38 334.16 136.26 88.83 54.18 40.79 39.55 38.35 37.62 26.81 33.70 29.40 33.14 39.05 45.23 43.11 41.95 45.93 27.97 13.92 13.919
EV/EBITDA 413.61 321.14 112.94 88.11 57.63 45.78 49.03 44.78 44.33 24.27 28.44 25.61 24.37 37.43 42.65 43.42 42.82 47.84 27.82 14.30 14.302
EV/Revenue 148.14 110.14 40.35 30.41 18.59 14.91 15.76 14.47 14.57 8.30 10.52 9.81 9.80 15.36 18.11 19.07 19.52 22.24 12.70 5.90 5.902
EV/EBIT 432.78 336.04 117.78 92.02 60.90 48.78 52.68 48.46 47.83 26.07 30.26 27.14 25.70 39.32 44.63 45.35 44.63 50.17 29.31 15.22 15.222
EV/FCF 332.64 332.11 132.64 86.43 51.24 38.01 36.67 34.96 34.15 23.20 30.48 26.16 29.81 36.52 42.94 40.77 40.06 44.27 26.36 11.99 11.987
Earnings Yield 0.2% 0.4% 1.1% 1.4% 2.0% 2.2% 1.7% 1.6% 1.6% 2.8% 2.4% 2.7% 2.9% 2.0% 1.9% 1.9% 1.9% 1.7% 2.7% 4.3% 4.31%
FCF Yield 0.3% 0.3% 0.7% 1.1% 1.8% 2.3% 2.4% 2.5% 2.6% 3.6% 2.9% 3.3% 2.9% 2.5% 2.1% 2.3% 2.3% 2.1% 3.5% 7.0% 6.99%
Price/Tangible Book snapshot only 5.471
EV/OCF snapshot only 11.658
EV/Gross Profit snapshot only 6.624
Acquirers Multiple snapshot only 17.707
Shareholder Yield snapshot only 9.50%
Graham Number snapshot only $10.50
Leverage & Solvency
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Current Ratio 7.89 8.68 9.36 8.12 7.24 7.18 8.49 6.99 7.46 7.00 8.03 6.20 6.72 7.24 8.74 6.97 6.47 7.79 6.63 6.09 6.093
Quick Ratio 7.89 8.68 9.30 8.12 7.24 7.18 8.49 6.99 7.46 7.00 8.03 6.20 6.72 7.24 8.74 6.97 6.47 7.79 6.63 6.09 6.093
Debt/Equity 0.00 0.00 0.00 0.00 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.011
Net Debt/Equity -1.00 -0.96 -0.91 -0.91 -0.85 -0.84 -0.84 -0.85 -0.87 -0.82 -0.80 -0.83 -0.81 -0.82 -0.81 -0.83 -0.81 -0.79 -0.74 -0.78 -0.777
Debt/Assets 0.00 0.00 0.00 0.00 0.01 0.02 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.009
Debt/EBITDA 0.03 0.01 0.02 0.01 0.10 0.12 0.12 0.12 0.11 0.10 0.09 0.08 0.07 0.06 0.06 0.05 0.04 0.04 0.04 0.04 0.038
Net Debt/EBITDA -27.88 -14.23 -8.56 -6.72 -6.56 -5.87 -6.08 -6.10 -5.97 -4.66 -4.01 -4.11 -3.71 -3.73 -3.56 -3.61 -3.08 -3.00 -2.49 -2.78 -2.775
Interest Coverage — — — — — — — — — — — — — — — — — — — — —
Equity Multiplier 1.14 1.13 1.11 1.13 1.16 1.17 1.15 1.18 1.16 1.18 1.16 1.20 1.18 1.16 1.14 1.17 1.17 1.15 1.18 1.18 1.182
Cash Ratio snapshot only 4.831
Cash to Debt snapshot only 73.500
FCF to Debt snapshot only 31.173
Defensive Interval snapshot only 906.8 days
Efficiency & Turnover
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Asset Turnover 0.09 0.17 0.27 0.35 0.38 0.41 0.40 0.39 0.40 0.44 0.45 0.43 0.44 0.48 0.51 0.49 0.52 0.52 0.55 0.54 0.540
Inventory Turnover — — 5.54 — — — 20.39 — — — — — — — — — — — — — —
Receivables Turnover 1.58 2.73 3.49 4.24 5.93 5.70 5.49 4.46 5.17 5.08 5.43 4.56 4.62 4.66 4.68 4.97 4.49 4.89 4.34 4.72 4.722
Payables Turnover 2.96 21.69 22.78 85.93 24.82 52.08 36.40 61.66 71.52 58.37 29.72 28.75 45.64 29.84 30.70 30.96 32.13 17.00 20.37 26.22 26.217
DSO 231 134 105 86 62 64 67 82 71 72 67 80 79 78 78 73 81 75 84 77 77.3 days
DIO 0 0 66 0 0 0 18 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 123 17 16 4 15 7 10 6 5 6 12 13 8 12 12 12 11 21 18 14 13.9 days
Cash Conversion Cycle 108 117 155 82 47 57 74 76 65 66 55 67 71 66 66 62 70 53 66 63 63.4 days
Fixed Asset Turnover snapshot only 25.570
Cash Velocity snapshot only 0.861
Capital Intensity snapshot only 1.743
Growth (YoY)
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue — — — — 4.0% 1.5% 60.8% 22.0% 20.8% 16.6% 16.6% 13.5% 13.0% 15.3% 17.5% 20.0% 19.4% 20.2% 15.9% 13.1% 13.05%
Net Income — — — — 4.7% 1.3% 0.7% -27.1% -21.2% -12.7% 15.8% 30.8% 35.1% 41.4% 46.3% 51.2% 46.4% 45.3% 18.9% -12.2% -12.16%
EPS — — — — 4.3% 1.3% 2.8% -26.0% -20.3% -10.6% 22.5% 38.4% 44.0% 47.5% 45.0% 49.8% 45.0% 45.1% 20.7% -8.6% -8.57%
FCF — — — — 3.1% 2.0% 1.3% 43.5% 42.2% 6.3% -6.4% 2.8% -13.0% 35.6% 43.6% 49.6% 77.2% 43.6% 32.4% 19.0% 19.03%
EBITDA — — — — 3.5% 1.4% 44.6% 14.2% 23.2% 22.4% 34.1% 34.5% 38.1% 38.4% 34.9% 37.6% 35.5% 36.2% 24.6% 6.2% 6.23%
Op. Income — — — — 3.4% 1.4% 40.4% 10.2% 20.6% 14.7% 28.9% 31.0% 35.4% 48.1% 42.7% 39.0% 31.1% 23.7% 8.1% -5.7% -5.65%
OCF Growth snapshot only 19.47%
Asset Growth snapshot only -11.12%
Equity Growth snapshot only -12.17%
Debt Growth snapshot only -17.84%
Shares Change snapshot only -3.92%
Growth (CAGR)
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue 3Y — — — — — — — — — — — — 89.4% 50.4% 30.1% 18.4% 17.7% 17.4% 16.7% 15.5% 15.45%
Revenue 5Y — — — — — — — — — — — — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — 82.2% 44.5% 22.2% 15.3% 18.5% 24.1% 28.9% 23.8% 23.76%
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — 82.7% 40.8% 19.5% 13.0% 15.9% 21.5% 26.3% 20.2% 20.23%
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — 96.8% 59.6% 37.8% 28.3% 32.1% 32.1% 31.1% 25.3% 25.26%
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — 89.8% 51.0% 30.8% 19.2% 18.8% 18.7% 17.8% 16.3% 16.27%
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — 93.5% 58.8% 37.2% 26.1% 28.9% 28.1% 25.7% 19.8% 19.77%
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — 71.1% 62.8% 45.1% 30.2% 29.9% 27.4% 21.2% 22.3% 22.33%
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — 71.8% 62.3% 44.2% 29.2% 28.6% 26.3% 20.6% 22.0% 22.04%
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y — — — — — — — — — — — — 8.9% 8.8% 7.9% 8.4% 4.6% 6.9% 2.7% -0.4% -0.39%
Assets 5Y — — — — — — — — — — — — — — — — — — — — —
Equity 3Y — — — — — — — — — — — — 7.8% 7.6% 7.1% 7.2% 4.4% 7.6% 1.7% -0.5% -0.53%
Book Value 3Y — — — — — — — — — — — — 7.5% 10.4% 9.6% 9.4% 6.7% 9.9% 3.9% 2.4% 2.40%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue Stability — — — — — — — — 0.90 0.90 0.95 0.99 0.85 0.89 0.96 0.99 0.99 0.99 1.00 0.99 0.991
Earnings Stability — — — — — — — — 0.51 0.54 0.78 0.03 0.61 0.76 0.78 0.45 0.80 0.87 0.89 0.50 0.499
Margin Stability — — — — — — — — 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.98 0.98 0.99 0.986
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 0.00 0.000
FCF Positive Streak 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence — — — — — — — — 0.92 0.95 0.94 0.88 0.86 0.83 0.81 0.50 0.81 0.82 0.92 0.95 0.951
Earnings Smoothness — — — — 0.00 0.23 0.99 0.69 0.76 0.86 0.85 0.73 0.70 0.66 0.62 0.59 0.62 0.63 0.83 0.87 0.871
ROE Trend — — — — — — — — 0.02 0.02 0.02 0.02 0.03 0.03 0.05 0.07 0.08 0.07 0.07 0.02 0.021
Gross Margin Trend — — — — — — — — -0.01 0.00 0.01 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.00 -0.01 -0.007
FCF Margin Trend — — — — — — — — 0.02 -0.00 -0.02 -0.01 -0.07 0.05 0.03 0.07 0.11 0.11 0.10 0.07 0.071
Sustainable Growth Rate 3.6% 8.1% 14.1% 17.3% 18.1% 16.7% 13.1% 12.2% 12.6% 14.1% 15.3% 15.8% 16.9% 19.0% 21.2% 22.5% 24.3% 24.6% 23.8% 19.3% 19.28%
Internal Growth Rate 3.3% 7.7% 14.5% 18.1% 18.6% 17.0% 13.1% 11.9% 12.1% 13.6% 15.4% 15.4% 16.8% 19.4% 22.7% 23.5% 26.0% 27.1% 25.9% 19.6% 19.65%
Cash Flow Quality
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
OCF/Net Income 1.26 0.84 0.67 0.82 0.92 1.12 1.51 1.59 1.62 1.34 1.21 1.25 1.05 1.28 1.19 1.22 1.25 1.26 1.32 1.67 1.665
FCF/OCF 0.98 0.96 0.95 0.95 0.95 0.95 0.96 0.97 0.97 0.97 0.97 0.97 0.96 0.97 0.97 0.98 0.98 0.98 0.97 0.97 0.973
FCF/Net Income snapshot only 1.619
OCF/EBITDA snapshot only 1.227
CapEx/Revenue 1.1% 1.3% 1.4% 1.7% 1.9% 2.0% 1.8% 1.5% 1.3% 1.1% 1.1% 1.2% 1.2% 1.2% 1.2% 1.1% 1.2% 1.2% 1.3% 1.4% 1.39%
CapEx/Depreciation snapshot only 0.557
Accruals Ratio -0.01 0.01 0.04 0.03 0.01 -0.02 -0.06 -0.06 -0.07 -0.04 -0.03 -0.03 -0.01 -0.05 -0.03 -0.04 -0.05 -0.06 -0.07 -0.11 -0.109
Sloan Accruals snapshot only -0.133
Cash Flow Adequacy snapshot only 36.423
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.01 $0.01 $0.01 $0.01 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 2.0% 2.0% 2.2% 2.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 2.5% 2.3% 2.0% 1.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 10.2% 4.3% 2.3% 3.7% 7.9% 51.8% 61.5% 75.6% 82.6% 1.6% 2.0% 1.9% 1.9% 96.9% 55.3% 53.9% 81.4% 75.2% 1.5% 2.2% 2.20%
Div. Increase Streak — — — 0 0 0 0 — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.1% 1.1% 1.0% 1.2% 1.4% 4.5% 5.0% 5.2% 5.6% 1.9% 1.0% 1.0% 1.6% 1.3% 4.2% 9.5% 9.50%
Net Buyback Yield -4.8% -3.2% -5.1% -4.9% 0.1% 1.1% 1.0% 1.2% 1.3% 4.5% 5.0% 5.2% 5.6% 1.9% 1.0% 1.0% 1.5% 1.2% 4.0% 9.2% 9.20%
Total Shareholder Return -4.8% -3.2% -5.1% -4.9% 0.2% 1.1% 1.0% 1.2% 1.3% 4.5% 5.0% 5.2% 5.6% 1.9% 1.0% 1.0% 1.5% 1.2% 4.0% 9.2% 9.20%
DuPont Factors
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Tax Burden (NI/EBT) 1.06 1.24 1.37 1.36 1.35 1.18 0.96 0.85 0.82 0.81 0.79 0.80 0.79 0.77 0.80 0.85 0.86 0.89 0.87 0.78 0.784
Interest Burden (EBT/EBIT) 1.00 1.01 1.01 1.00 1.01 1.01 1.03 1.06 1.09 1.06 1.07 1.08 1.08 1.12 1.13 1.10 1.06 1.04 1.00 1.00 1.000
EBIT Margin 0.34 0.33 0.34 0.33 0.31 0.31 0.30 0.30 0.30 0.32 0.35 0.36 0.38 0.39 0.41 0.42 0.44 0.44 0.43 0.39 0.388
Asset Turnover 0.09 0.17 0.27 0.35 0.38 0.41 0.40 0.39 0.40 0.44 0.45 0.43 0.44 0.48 0.51 0.49 0.52 0.52 0.55 0.54 0.540
Equity Multiplier 1.14 1.13 1.11 1.13 1.15 1.15 1.13 1.15 1.16 1.17 1.15 1.19 1.17 1.17 1.15 1.18 1.17 1.16 1.16 1.17 1.174
Per Share
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
EPS (Diluted TTM) $0.13 $0.29 $0.55 $0.72 $0.70 $0.66 $0.56 $0.53 $0.56 $0.59 $0.69 $0.73 $0.81 $0.87 $1.00 $1.10 $1.17 $1.26 $1.20 $1.01 $1.01
Book Value/Share $3.69 $3.57 $3.88 $4.07 $4.20 $4.11 $4.39 $4.54 $4.67 $4.17 $4.31 $4.48 $4.59 $4.80 $5.10 $5.33 $5.10 $5.46 $4.92 $4.88 $5.02
Tangible Book/Share $3.55 $3.44 $3.75 $3.95 $3.72 $3.63 $3.91 $4.07 $4.20 $3.70 $3.83 $4.01 $4.11 $4.33 $4.64 $4.89 $4.65 $4.84 $4.30 $4.26 $4.26
Revenue/Share $0.37 $0.70 $1.15 $1.59 $1.68 $1.80 $1.89 $1.97 $2.06 $2.14 $2.34 $2.36 $2.48 $2.58 $2.72 $2.81 $2.93 $3.10 $3.20 $3.31 $3.59
FCF/Share $0.16 $0.23 $0.35 $0.56 $0.61 $0.70 $0.81 $0.82 $0.88 $0.77 $0.81 $0.89 $0.81 $1.08 $1.15 $1.31 $1.43 $1.55 $1.54 $1.63 $1.64
OCF/Share $0.17 $0.24 $0.37 $0.59 $0.64 $0.74 $0.85 $0.84 $0.90 $0.79 $0.83 $0.92 $0.84 $1.12 $1.18 $1.35 $1.46 $1.59 $1.58 $1.67 $1.68
Cash/Share $3.68 $3.43 $3.54 $3.70 $3.61 $3.51 $3.78 $3.95 $4.11 $3.49 $3.54 $3.79 $3.77 $4.02 $4.18 $4.51 $4.18 $4.38 $3.69 $3.84 $3.77
EBITDA/Share $0.13 $0.24 $0.41 $0.55 $0.54 $0.59 $0.61 $0.64 $0.68 $0.73 $0.86 $0.91 $1.00 $1.06 $1.16 $1.23 $1.34 $1.44 $1.46 $1.36 $1.36
Debt/Share $0.00 $0.00 $0.01 $0.01 $0.05 $0.07 $0.07 $0.07 $0.07 $0.07 $0.08 $0.07 $0.07 $0.07 $0.06 $0.06 $0.06 $0.06 $0.05 $0.05 $0.05
Net Debt/Share $-3.68 $-3.42 $-3.53 $-3.69 $-3.56 $-3.43 $-3.70 $-3.88 $-4.04 $-3.42 $-3.47 $-3.72 $-3.70 $-3.95 $-4.11 $-4.45 $-4.12 $-4.32 $-3.64 $-3.79 $-3.79
Per Employee
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Employee Count snapshot only 880
Revenue/Employee snapshot only $732798.86
Income/Employee snapshot only $222785.23
EBITDA/Employee snapshot only $302372.73
FCF/Employee snapshot only $360789.77
Assets/Employee snapshot only $1276917.05
Market Cap/Employee snapshot only $5163756.59
Academic Models
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 17.861
Altman Z-Prime snapshot only 33.559
Piotroski F-Score 4 3 3 3 4 6 5 6 7 7 7 8 8 9 8 8 6 8 7 6 6
Beneish M-Score — — — — -0.65 -0.84 -2.27 -2.23 -2.64 -2.52 -2.37 -2.66 -2.23 -2.45 -2.29 -2.42 -2.54 -2.68 -2.66 -2.91 -2.909
Ohlson O-Score snapshot only -13.702
ROIC (Greenblatt) snapshot only 30.69%
Net-Net WC snapshot only $3.96
EVA snapshot only $147295652.92
Credit
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Credit Rating snapshot only AA+
Credit Score 93.87 93.71 93.98 94.06 94.19 93.60 94.56 94.03 94.06 93.79 93.88 93.56 93.90 93.44 93.70 92.94 93.27 92.61 93.62 93.06 93.062
Credit Grade snapshot only 2
Credit Trend snapshot only 0.123
Implied Spread (bps) snapshot only 65.000
Industry Credit Rank snapshot only 87
Sector Credit Rank snapshot only 88

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms